Actualités

Warren Buffett’s conglomerate bought $16 billion of stocks and sold $24 billion in the first quarter, a regulatory filing reveals.

For years, investors treated Warren Buffett’s Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) as the market’s ultimate “follow-the-smart-money” signal. If Buffett bought, retail investors paid attention. If he sold, Wall Street usually started asking uncomfortable questions. Now Berkshire Hathaway has given investors another one to chew on. According to Berkshire’s latest SEC 13F filing, the conglomerate completely exited its ... Warren Buffett’s Berkshire Big Shakeup Continues: UnitedHealth Stake C

Berkshire Hathaway has fully exited its position in UnitedHealth Group (NYSE:UNH) under Greg Abel's leadership. The sale removes a high profile institutional investor from UnitedHealth's shareholder base. The move is separate from recent earnings, guidance, or valuation developments for UnitedHealth Group. For investors watching UnitedHealth Group at a current share price of $393.85, Berkshire Hathaway's exit comes after a period of strong recent stock performance. NYSE:UNH is up 3.7% over...

Berkshire Hathaway added stakes in Delta and Macy's during Greg Abel's first quarter as CEO of the conglomerate, while eliminating holdings in Amazon and other major companies.

Berkshire Hathaway boosted its stake in Alphabet to nearly 58 million shares on March 31 from almost 18 million shares at year-end.

Here's what investing conglomerate Berkshire Hathaway was buying and selling during the first quarter, the first period for Greg Abel at the helm since succeeding Warren Buffett as CEO. Delta Air Lines: Berkshire bought a sizable stake worth around $2.

Berkshire Hathaway took new positions in Delta Air Lines and Macy’s during its first quarter with Greg Abel as chief executive. The company also exited its positions in Amazon.com Domino’s Pizza, Mastercard Visa and UnitedHealth Group among others, during the March quarter. The exited holdings, all on the smaller side in Berkshire’s stock portfolio, might have been positions managed by former investment manager Todd Combs.

The Dow has got it going. The blue-chip index rose 371 points or 0.8% and closed above 50,000 for the first time since Feb. 11. The S&P 500 rose 0.8%, while Nasdaq rose 0.9%, and both hit new closing highs.

UnitedHealth Group (NYSE:UNH) is back in every headline, riding a 31.24% one-month bounce off a 9.38% Q1 EPS beat that had Reddit cheering a “UnitedHealth +7% premarket” rally on April 21. But here’s what you should actually be watching. Why The UNH Bounce Looks Like a Trap One quarter does not undo the damage. Full-year ... Forget UnitedHealth: Two Stocks To Buy Now

The Dow, among the oldest stock market indicators, was up as much as 500 points today, or nearly a percent. The index could use some more semiconductor stocks. It would help the Dow keep up with S&P 500 and Nasdaq, which have clocked in one all-time high after another.

Roughly a year ago, 24/7 Wall St. ran a piece titled Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now, arguing that Cardinal Health (NYSE: CAH) was the safer healthcare bet while UnitedHealth Group (NYSE: UNH) reeled from a Department of Justice probe, a leadership shake-up, and a 50% drawdown. Twelve ... Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It?

Stocks opened higher after a pair of healthy economic reports, with the Dow getting a boost to 50,000 from Cisco’s strong earnings. The Dow was up 0.8%, to trade at 50,080.30. The picture for the U.S. economy is positive, with retail sales coming in healthy and jobless claims showing the labor market continues to hum.

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

This top Wall Street firm is convinced about UnitedHealth's prospects. Is it right?

ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.

UnitedHealth has substantially underperformed the broader market over the past year amid regulatory and operational challenges, although analysts continue to maintain a cautiously constructive view on the company’s long-term growth prospects.

If it feels like growth stocks can’t continue their outperformance much longer, ignore that feeling. The Vanguard S&P 500 Growth Index Fund Exchange-Traded Fund, home to companies with high sales growth including Nvidia Advanced Micro Devices Microsoft and Eli Lilly is up 13% in the past month. A couple of factors have driven the performance of the growth stocks.

The health insurance and healthcare services giant is early in its turnaround plans.

U.S. stock markets closed mixed on Tuesday following hotter-than-expected key inflation data.

U.S. stock markets closed mixed on Tuesday following hotter-than-expected key inflation data.

UnitedHealth Group Incorporated (NYSE:UNH) is one of the top “blue chip” stocks that were suddenly on fire in April. JPMorgan lifted the price target on UnitedHealth Group Incorporated (NYSE:UNH) to $420 from $389 on April 28, reiterating an Overweight rating on the shares. UnitedHealth Group Incorporated (NYSE:UNH) also received a rating update from Goldman Sachs on […]

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...

UNH's Optum Rx unveils a transparent, fee-based PBM model, ditching spread pricing and adding real-time cost tools as regulators push for lower drug pricing.

Clients of the drug middleman can pay monthly fees per member that aren’t linked to manufacturers’ list prices or prescription volume.

UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.

Optum Rx, part of UnitedHealth Group, has rolled out a new fee-based pharmacy benefit management model that removes traditional volume-linked drug pricing. The model is paired with digital tools that show prescription level cost estimates to payers and patients. This change is intended to increase pricing clarity, align incentives across the drug supply chain, and influence how pharmacy benefits are structured. For investors watching NYSE:UNH, this move comes with the stock at a share price...

UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.

If it feels like growth stocks can’t continue their outperformance much longer, ignore that feeling. The Vanguard S&P 500 Growth Index Fund Exchange-Traded Fund, home to companies with high sales growth including Nvidia Advanced Micro Devices Microsoft and Eli Lilly is up 13% in the past month. A couple of factors have driven the performance of the growth stocks.

Nvidia and Boeing lead five Dow stocks to watch near buy points this week. Nvidia stock and its peers have rallied in a soaring stock market, with earnings out of the way for some of these names but not for others. Walmart, Goldman Sachs and UnitedHealth also make the cut.

UnitedHealth Group (UNH) has been in focus after first quarter 2026 earnings, a higher full year earnings outlook, and plans to cut prior authorization requirements, while analysts highlighted the stock following these updates. See our latest analysis for UnitedHealth Group. The stock has reacted strongly to the first quarter earnings update and guidance lift, with a 30 day share price return of 20.15% and 90 day share price return of 33.65%. However, the 1 year total shareholder return is...